BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 30717767)

  • 21. CRISPR-Cas12a/Cpf1-assisted precise, efficient and multiplexed genome-editing in
    Yang Z; Edwards H; Xu P
    Metab Eng Commun; 2020 Jun; 10():e00112. PubMed ID: 31867213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum.
    Zhao N; Li L; Luo G; Xie S; Lin Y; Han S; Huang Y; Zheng S
    J Ind Microbiol Biotechnol; 2020 Aug; 47(8):599-608. PubMed ID: 32876764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art.
    Ciurkot K; Vonk B; Gorochowski TE; Roubos JA; Verwaal R
    J Vis Exp; 2019 May; (147):. PubMed ID: 31205318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing.
    Li B; Zeng C; Li W; Zhang X; Luo X; Zhao W; Zhang C; Dong Y
    Cell Rep; 2018 Dec; 25(12):3262-3272.e3. PubMed ID: 30566855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference.
    Zhao Y; Boeke JD
    Nucleic Acids Res; 2020 Jun; 48(10):5788-5798. PubMed ID: 32374858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant Gene Knockout and Knockdown by CRISPR-Cpf1 (Cas12a) Systems.
    Zhang Y; Zhang Y; Qi Y
    Methods Mol Biol; 2019; 1917():245-256. PubMed ID: 30610641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
    Naduthodi MIS; Barbosa MJ; van der Oost J
    Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang.
    Bin Moon S; Lee JM; Kang JG; Lee NE; Ha DI; Kim DY; Kim SH; Yoo K; Kim D; Ko JH; Kim YS
    Nat Commun; 2018 Sep; 9(1):3651. PubMed ID: 30194297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.
    Zhang H; Li Z; Daczkowski CM; Gabel C; Mesecar AD; Chang L
    Cell Host Microbe; 2019 Jun; 25(6):815-826.e4. PubMed ID: 31155345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells.
    Kissling L; Monfort A; Swarts DC; Wutz A; Jinek M
    Methods Enzymol; 2019; 616():241-263. PubMed ID: 30691645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single Multiplex crRNA Array for FnCpf1-Mediated Human Genome Editing.
    Sun H; Li F; Liu J; Yang F; Zeng Z; Lv X; Tu M; Liu Y; Ge X; Liu C; Zhao J; Zhang Z; Qu J; Song Z; Gu F
    Mol Ther; 2018 Aug; 26(8):2070-2076. PubMed ID: 29910177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression.
    Yoon AR; Jung BK; Choi E; Chung E; Hong J; Kim JS; Koo T; Yun CO
    Mol Ther; 2020 Oct; 28(10):2286-2296. PubMed ID: 32682455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12a.
    Li W; Chan C; Zeng C; Turk R; Behlke MA; Cheng X; Dong Y
    Bioconjug Chem; 2020 Mar; 31(3):542-546. PubMed ID: 32119776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA.
    Jedrzejczyk DJ; Poulsen LD; Mohr M; Damas ND; Schoffelen S; Barghetti A; Baumgartner R; Weinert BT; Warnecke T; Gill RT
    Sci Rep; 2022 Jul; 12(1):12193. PubMed ID: 35842430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplexed activation in mammalian cells using a split-intein CRISPR/Cas12a based synthetic transcription factor.
    Bryson JW; Auxillos JY; Rosser SJ
    Nucleic Acids Res; 2022 Jan; 50(1):549-560. PubMed ID: 34908140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.
    Ishibashi R; Maki R; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2022 Oct; 12(1):17775. PubMed ID: 36272994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing.
    Wei J; Liu J; Wang Z; Yang Y; Tian Y; Wang S; Gao BQ; Gao S; Yang L; Tang J; Wang Y
    PLoS Biol; 2024 Jun; 22(6):e3002680. PubMed ID: 38865309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
    Yang F; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel and Efficient Genome Editing Tool Assisted by CRISPR-Cas12a/Cpf1 for
    Zhang X; Gu S; Zheng X; Peng S; Li Y; Lin Y; Liang S
    ACS Synth Biol; 2021 Nov; 10(11):2927-2937. PubMed ID: 34644057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.